Drug Type Recombinant polypeptide |
Synonyms ZT006 |
Target |
Mechanism GLP-1R modulators(Glucagon-like peptide 1 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | IND Approval | CN | 05 Nov 2024 | |
Obesity | IND Approval | CN | 05 Nov 2024 |